A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins

1K views

DOI:

10.3791/69328

October 31st, 2025

In This Article

Summary

This protocol describes a non-integrative, episomal CRISPR/dCas9-based system for targeted epigenetic editing in K562 cells, combining dCas9-DNMT3A and dCas9-HDAC1 effectors with specific sgRNAs to induce locus-specific DNA methylation with precision and reduced off-target effects.

Abstract

Investigating the precise role of DNA methylation in gene transcriptional regulation and developing therapies targeting specific gene methylation patterns presents significant challenges due to the scarcity of versatile tools capable of inducing site-specific and long-term epigenetic modifications for modulating gene expression. The study aimed to develop and validate an innovative episomal-based system to facilitate stable DNA methylation at a targeted gene locus, potentially useful for both basic epigenetic research and therapeutic applications. To achieve this, the K562 cell line was co-transfected with two distinct episomal vectors. Both vector types were engineered to express guide RNAs (gRNAs) targeting a 367 bp unmethylated region within the CpG island 326, located upstream of the ZBTB7A gene. Each vector encoded a deactivated form of endonuclease Cas9 (dead or dCas9) fused to either the catalytic domain of DNA methyltransferase DNMT3A (dCas-DNMT3A-CD) or the full-length histone deacetylase HDAC1 (dCas-HDAC1). The dCas sequence included two Nuclear Localization Signals (NLS) to ensure the protein's nuclear import. This dual system expression cassette promotes a chromatin state potentially conducive to long-term epigenetic silencing, promising robust and durable epigenetic results. This intervening approach to the host epigenome via utilization of self-replicating episomal vectors offers several advantages: maintenance and expression of vectors at low copy numbers throughout multiple cell divisions without integration into the host genome, hence minimizing off-target effects and preserving genome integrity. We report the precise and significant increase of DNA methylation at the targeted ZBTB7A CpG island 326. The findings validate that the engineered episomal CRISPR/dCas systems can elicit durable, site-specific DNA methylation. Therefore, this system is a valuable research tool for evaluating the functional effects of targeted methylation changes and a promising platform for developing future epigenetic treatments.

Introduction

Epigenetic regulation, including DNA methylation and histone modifications, plays a pivotal role in controlling gene expression, cell differentiation, and genome stability. Dysregulation of these mechanisms is often involved - either as a cause or a consequence - in various pathological states, particularly in cancer, neurological disorders, and imprinting syndromes1,2,3. Notably, by precisely intervening to the epigenetic landscape at specific genomic loci using epigenome editing Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) technology, gene repression l....

Access restricted. Please log in or start a trial to view this content.

Protocol

1. Design of sgRNAs

  1. Identify the desired CpG island or regulatory CpG sites within the promoter region of the gene of interest using a genome browser (e.g., UCSC genome browser). Here, the design was applied on the CpG island 326 (GRCh38)of the ZBTB7A gene.
  2. Design single guide RNAs (sgRNAs) using an online CRISPR sgRNA design platform [e.g., CHOPCHOP web tool (version 3)]. When designing sgRNAs, follow the recommendations below to ensure high on-target activity and minimal off-target effects:
    1. Select SpCas9 protein as the endonuclease, using 5'-NGG-3' as the protospacer adjacent motif at the 3....

Access restricted. Please log in or start a trial to view this content.

Results

To investigate whether our targeted epigenetic editing tools could induce site-specific DNA methylation changes at the ZBTB7A CpG island 326, we first generated episomal vectors encoding dCas9 fused to either DNMT3A(CD) or HDAC1, along with various sgRNAs designed with target sites within CpG island 326. We initially co-transfected K562 cells with combinations of these plasmids to evaluate whether simultaneous delivery of sgRNA and effector modules could lead to reproducible epigenetic modifications.

Access restricted. Please log in or start a trial to view this content.

Discussion

One of the most critical steps in this protocol is the design of highly specific sgRNAs. Off-target effects are a known limitation of CRISPR-based epigenetic editing systems, which can often arise from dCas9 binding infidelity, as well as the non-specific activity of the effector domains. To minimize this, sgRNAs must be designed using bioinformatic tools that optimize for high on-target activity and minimal off-target binding30. Employing design tools and validating predicted off-target sites is .......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors declare no competing financial or non-financial interests.

Acknowledgements

Irene Dereki and Vasiliki Chondrou are supported by a three-year fellowship (Grant No. 80706) from the Special Account of Research Funds (ELKE) of the Hellenic Open University.

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
Absolute Q DNA Digital PCR Master Mix (5x)Applied BiosystemsA52490
AgeI-HF NEBR3552
AscINEBR0558
AseINEBR0526
BamHI-HFNEBR3136
BD FACS Melody Cell SorterBD
BglllNEBR0144
BspEINEBR0540
Deoxynucleotide (dNTP) Solution Mix (10 mM each)NEBN0447
DMEM High Glucose w/stable Glutamine, w/Sodium Pyruvate mediumBiowestL0103
DNA Polymerase I, Large (Klenow) FragmentNEBM0210
DNMT3A (CD), HDAC1 sequencesIDT
DreamTaq DNA Polymerase Thermo ScientificEP0712
EpiTectQiagen59104Bisulfite conversion kit 
Epitect Bisulfite kitQiagen59104
Esp3INEBR0734
Fetal Bovine SerumGibcoA5256701
Geneticin selective antibiotic (G418 sulfate)Gibco11811031
Lipofectamine 3000 transfection kitInvitrogenL3000015
NEB® 5-alpha Competent E. coli (High Efficiency)NEBC2987I
NEB® 5-alpha F'Iq Competent E. coli (High Efficiency)NEBC2992H
Nucleospin Tissue Macherey-Nagel740952.50
PBS, 10x solution pH 7.4LonzaBE17-517Q
Penicillin-Streptomycin solution 100xBiowestL0022
pGuide vectorOriGene TechnologiesGE100042
Phenol:Chloroform:Isoamyl Alcohol 25:24:1 Saturated with 10 mM Tris, pH 8.0, 1 mM EDTASigma-AldrichP2069
Primers, sgRNAs Eurofins
PyroMark Assay Design QiagenVersion 2.0Bisulfite primer design tool 
PyroMark Gold Q24 ReagentsQiagen970802
PyroMark PCR kit Qiagen978703
PyroMark Q24 MDxQiagenPyrosequencing workstation 
PyroMark Q24 Software Qiagenv2.0.8Pyrosequencing software 
Q5® High-Fidelity DNA PolymeraseNEBM0491
QuantiTect Reverse Transcription KitQiagen205311
QuantStudio Absolute Q MAP16 Plate KitApplied BiosystemsA52865Digital PCR system 
SYBR Green I Nucleic Acid Gel Stain, 10,000x concentrate in DMSOInvitrogenS7563
T4 DNA LigaseNEBM0202
T4 Polynucleotide KinaseNEBM0201
TRIzol ReagentInvitrogen15596026

References

  1. Firdaus, Z., Li, X. Epigenetic explorations of neurological disorders, the identification methods, and therapeutic avenues. Int J Mol Sci. 25 (21), 11658(2024).
  2. Yu, X., et al. Cancer epigenetics: from laborato....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

dCas9-HDAC1Episomal VectorsTargeted MethylationCRISPR EpigeneticsFlow CytometryGene Regulation